Skip to content

The reliability of the measurement of how well blood flows through the kidneys to predict acute kidney injury in a population of ICU patients

Renal resistive index as an early predictor of acute kidney injury in a general ICU cohort: A prospective observational study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/11/077234
Enrollment
76
Registered
2024-11-22
Start date
Unknown
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R69- Illness, unspecified

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

Dr Sasidhar Datla
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Critically ill patients aged 18 years or older admitted to the ICU with a predicted length of stay exceeding 24 hours and no baseline AKI.

Exclusion criteria

Exclusion criteria: 1. Pre-existing chronic kidney disease, known renal artery stenosis, pregnancy. 2. Post cardiac arrest resuscitated patients. poor abdominal echogenicity, severe acute or chronic renal insufficiency defined as eGFR less than 30 ml/min/ 1.73m2, dialysis dependency, renal transplantation, mono-kidney, kidney tumour, anatomic kidney abnormalities. 3. Discharged within 24hrs.

Design outcomes

Primary

MeasureTime frame
To derive an association between RENAL RESISTIVITY INDEX and incidence of AKITimepoint: Day 0 (Baseline), Day 1 (24-48 hours), Day 2 (48-72 hours)

Secondary

MeasureTime frame
To Assess the relationship between RRI & AKI severity & mortality.Timepoint: Day 0 (Baseline), Day 1 (24-48 hours), Day 2 (48-72 hours);To Evaluate the predictive performance of RRI compared to conventional AKI diagnostic methods (serum creatinine, urine output).Timepoint: Day 0 (Baseline), Day 1 (24-48 hours), Day 2 (48-72 hours);To Identify the optimal cut-off value of RRI for AKI prediction.Timepoint: Day 0 (Baseline), Day 1 (24-48 hours), Day 2 (48-72 hours)

Countries

India

Contacts

Public ContactDr Arjun Alva

Narayana Health

arjun.alva.dr@narayanahealth.org9108026001

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026